PsyBio Therapeutics Augments Intellectual Property Portfolio with Filing of Next Novel Psychedelic Compositions and… Jul 13, 2021
MINDCURE Announces Filing of U.S. Provisional Patent Applications for Company’s First Fully Synthetic Routes to… Jul 13, 2021
DigiMax Global Inc. Discusses its Ability to Unlock the Potential of Disruptive Technologies in Audio Interview with… Jul 12, 2021
Numinus Announces Health Canada Approval of MAPS-Sponsored Open Label Study for MDMA-Assisted Therapy for PTSD Jul 12, 2021
